Committee for Orphan Medicinal Products (COMP): 22-24 May 2018
Date:
22/05/2018 to 24/05/2018
Location:
European Medicines Agency, London, UK
The Committee for Orphan Medicinal Products (COMP) is the committee that is responsible for reviewing applications for 'orphan medicinal product designation' for medicines intended for the diagnosis, prevention or treatment of rare diseases.
-
List item
Minutes of the COMP meeting of 22-24 May 2018 (PDF/198.62 KB)
Adopted
First published: 17/08/2018
Last updated: 17/08/2018
EMA/COMP/316876/2018 -
List item
COMP meeting report on the review of applications for orphan designation: May 2018 (PDF/131.24 KB)
First published: 14/06/2018
Last updated: 14/06/2018
EMA/COMP/270019/2018 -
List item
Agenda - COMP agenda of the 22-24 May 2018 meeting (PDF/264.42 KB)
Draft
First published: 22/05/2018
Last updated: 22/05/2018
EMA/COMP/251740/2018